BridgeMD

Sign in

Cardiomyopathies clinical trials

Explore recruiting cardiomyopathies clinical trials.

Recruiting cardiomyopathies studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cardiomyopathies trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Adjunctive DobutAmine in sePtic cardiomyopathy with Tissue hypoperfusion: a randomized controlled multi-center trial

France

Phase III and phase IV (Integrated) EU CTIS Study details

SUPPRESS. Prophylactic frequent premature ventricular complexeS sUPPression on left ventriculaR function impairmEnt in aSymptomatic patientS

France

Phase III and phase IV (Integrated) EU CTIS Study details

SECRET-HF: Treatment of Non-ischemic Dilated Cardiomyopathies by Intravenous Infusions of the Extracellular Vesicle-Enriched Secretome of Cardiovascular Progenitor Cells

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Single-blinded randomized investigator-initiated controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy with myocarditis (chronic inflammatory cardiomyopathy) – Trial and Registry to study the role of genotype environment interaction in Chronic myocarditis and inflammatory cardiomyopathies with ventricular pro-arrhythmic and heart failure phenotypes (PNRR-MAD-2022-12376225)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cardiomyopathies trials by city

Cardiomyopathies in Toronto Cardiomyopathies in Vancouver Cardiomyopathies in Montreal Cardiomyopathies in Calgary Cardiomyopathies in Edmonton Cardiomyopathies in Ottawa Cardiomyopathies in Winnipeg Cardiomyopathies in Quebec City Cardiomyopathies in Hamilton Cardiomyopathies in Kitchener Cardiomyopathies in London Cardiomyopathies in Halifax Cardiomyopathies in New York Cardiomyopathies in Los Angeles Cardiomyopathies in Chicago Cardiomyopathies in Houston